Medical X

What Medical X does

Medical X, Inc. operates a single outpatient medical detoxification facility in North Scottsdale, Arizona, serving individuals suffering from drug and alcohol dependence. Founded in 2015 by Dr. Steven Locnikar, a board-certified physician with dual credentials in Facial Plastic Surgery and Otolaryngology and nearly 20 years of addiction medicine experience, the clinic delivers medically supervised withdrawal management using IV fluids, nutritional supplementation, comfort medications, and FDA-approved medication-assisted treatment (MAT) including buprenorphine (Suboxone, Sublocade), naltrexone, and extended-release Vivitrol injections. The product surface spans opioid detox, alcohol detox, polysubstance detox, buprenorphine treatment, naltrexone treatment, IV therapy, and Vivitrol maintenance, all delivered in a confidential outpatient setting with private rooms, massage chairs, and HDTVs.

The underlying technology is a clinical protocol stack rather than a software platform: protocols combine IV therapy with FDA-approved pharmacotherapy and physician oversight, with no proprietary software, AI tools, or tele-health delivery disclosed. The website runs on WordPress and the digital presence is limited to Facebook, LinkedIn, YouTube, email, and educational blog content. Services are delivered on a per-visit professional services basis with insurance acceptance, but pricing is not publicly disclosed.

The go-to-market motion is sales-led and localized: patients reach the clinic via direct phone (480-219-0055), website inquiries, and community outreach, with same-day appointment availability and optional weekend hours. The company is founder-owned and bootstrapped with no evidence of outside investment, no parent company, no partnerships, and no institutional customers. The business is effectively a solo-physician private practice; no enterprise customers, payer contracts, or referral network breadth is disclosed, and the addressable market is the Arizona community with above-national-average illicit drug use.

Name

Medical X

Legal name

Medical X, Inc.

Website

https://medxscottsdale.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

Medical X is a private, single-location outpatient detox clinic in Scottsdale, Arizona, founded in 2015 by Dr. Steven Locnikar. It provides medically supervised drug and alcohol withdrawal management, IV therapy, and FDA-approved medication-assisted treatment (buprenorphine, naltrexone, Vivitrol) to individuals with substance use disorders in the Arizona market.

Ownership category

akta.pro rank

Product category

Addiction Treatment Services

NAICS

Outpatient Mental Health and Substance Abuse Centers (621420), Other Ambulatory Health Care Services (6219)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Substance Use Detoxification Centers (Medical Detox) (HLAFACAD)

akta.pro secondary industries

Outpatient Substance Use Treatment Programs (IOP/PHP/OP) (HLAFACAF), Outpatient Substance Use Disorder (SUD) Treatment Programs (HLAFABAD)

Keywords

• Outpatient detox services
• Medication-assisted treatment
• Addiction medicine services
• Substance use treatment
• IV therapy detox

Headquarters

HQ city

Scottsdale

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Supply Chain, Technology or R&D

Revenue model

1. Outpatient Detox Services: Medical X generates revenue through fees for medically supervised outpatient detoxification services, including initial assessments, treatment plans, IV therapy, medication administration, and ongoing patient monitoring. Services are provided on a per-visit basis with treatment plans varying in duration from single visits to ongoing maintenance programs.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Medical X provides medically supervised outpatient detoxification for individuals suffering from drug and alcohol dependence at its Scottsdale, Arizona facility. The practice combines IV therapy, vitamins and supplements, and FDA-approved medications (buprenorphine, naltrexone/Vivitrol, Sublocade) with comfort medications to manage withdrawal symptoms. Services are delivered in private rooms under physician supervision, enabling patients to begin recovery while maintaining daily responsibilities.

Product overview

Medical X operates as an outpatient detoxification facility offering a unified suite of medically supervised detox and medication-assisted treatment services. The core offering is outpatient drug and alcohol detox, which is enhanced through complementary treatment modules including Buprenorphine Treatment (Suboxone, Subutex, Sublocade formulations), Naltrexone/Vivitrol Treatment, and IV Therapy for withdrawal support. Services target substance use disorders including opioid addiction, alcohol use disorder, and polysubstance dependence. The company was founded in 2015 and is led by Dr. Steven Locnikar.

Differentiator

Problem solved

Functional benefit

Products and services

• Opioid Detox Medically supervised outpatient opioid withdrawal treatment for individuals addicted to prescription painkillers, heroin, or fentanyl. The program administers medication and IV fluids to reduce withdrawal symptom severity and incorporates medication-assisted treatment with buprenorphine products.
• Buprenorphine Treatment FDA-approved medication-assisted treatment for opioid use disorder using buprenorphine, a partial opioid agonist that suppresses cravings and withdrawal symptoms while having a ceiling effect that reduces overdose risk. Available in sublingual formulations (Suboxone, Zubsolv, Bunavail, Subutex) and the long-acting injectable Sublocade.
• Naltrexone Treatment FDA-approved medication-assisted treatment for both alcohol use disorder and opioid use disorder. Available in oral pill form and as the extended-release injectable Vivitrol, naltrexone blocks the euphoric effects of opioids and reduces cravings to support relapse prevention.
• Alcohol Detox Medically supervised outpatient alcohol withdrawal treatment providing nutrient IV therapy and medication-assisted treatment in a confidential setting with physician oversight, designed to safely manage withdrawal symptoms and support long-term sobriety.
• IV Therapy Intravenous therapy delivering vitamins, minerals, medications, and amino acids directly into the body for maximum absorption during drug and alcohol detox, used to reduce withdrawal symptoms, suppress cravings, and replenish depleted fluids and nutrients.
• Polysubstance Detox Medically supervised outpatient detoxification for individuals dependent on multiple substances, including opioids, alcohol, benzodiazepines, cocaine, methamphetamine, methadone, and other drugs, with customized protocols for combined withdrawal management.
• Vivitrol Treatment Extended-release injectable naltrexone (Vivitrol) medication-assisted treatment for alcohol dependence and opioid use disorder, administered monthly after detoxification to prevent relapse by blocking opioid euphoric effects.

Quantifiable outcome

• Very low recidivism rate of alcohol relapse based on medications, physician knowledge, and patient desire to remain sober

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• CleanSlate Outpatient Addiction Medicine: Multi-state outpatient MAT provider offering buprenorphine, naltrexone/Vivitrol, and Sublocade in office-based settings. Most directly comparable peer given shared outpatient MAT model, FDA-approved medication toolkit, and per-visit fee structure.
• Groups: Recover Together: Office-based outpatient MAT provider using buprenorphine and group therapy. Comparable to Medical X in outpatient detox/MAT focus, insurance-based revenue model, and emphasis on opioid use disorder.
• BrightView Health: Outpatient addiction treatment provider offering MAT, detox, and counseling across multiple states. Closely aligned with Medical X on outpatient MAT delivery, medication protocols, and patient demographic.

Emerging players

• Boulder Care: Telehealth-first MAT provider offering buprenorphine, naltrexone, and Sublocade via virtual care. Comparable on MAT protocols and patient demographic, but differentiated by telehealth delivery vs. Medical X's in-clinic model.
• Workit Health: Telehealth MAT provider offering buprenorphine and Sublocade with online counseling. Comparable on MAT protocol and patient demographic, but telehealth-first delivery contrasts with Medical X's in-person clinic model.
• Eleanor Health: Outpatient addiction and mental health provider combining MAT with therapy and case management. Comparable on whole-person outpatient SUD treatment model, though operates at larger scale across multiple states.

Broad incumbents

• Caron Treatment Centers: Established nonprofit addiction treatment provider with residential and outpatient programs. Comparable on SUD treatment focus and MAT services; far larger and primarily residential-based.
• Hazelden Betty Ford Foundation: Nationally recognized addiction treatment operator offering inpatient, outpatient, and MAT services. Comparable on substance use disorder treatment scope; much larger scale and predominantly residential rather than outpatient-only.
• American Addiction Centers: Multi-facility addiction treatment operator offering detox, residential, and outpatient services. Comparable on treatment service mix including MAT; operates at significantly larger national scale than Medical X.

Regional players

• Scottsdale Recovery Center: Arizona-based outpatient and residential addiction treatment provider offering detox and MAT. Direct geographic competitor in the Scottsdale/Phoenix market with overlapping patient base and service mix.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/medicalx
• LinkedInlinkedin.com/company/medical-x-inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medical X